• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
IVX
Click for more information
10.0% 0.6¢

INVION LIMITED

Market Cap $35.33M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare

Invion Limited is an Australia-based life science company. The Company is engaged in the... Invion Limited is an Australia-based life science company. The Company is engaged in the research and development of Photosoft technology for the treatment of a range of cancers, atherosclerosis and infectious diseases. The Company is developing Photosoft technology as a Photodynamic Therapy (PDT). PDT uses non-toxic photosensitizers and light to selectively kill cancer cells and promote an anti-cancer immune response. PDT also offers an alternative treatment option aimed at achieving complete tumor regression and long-lasting remission. PDT has also demonstrated broad-spectrum activity across multiple infectious diseases, including bacteria, fungi and viruses. It holds the Australia and New Zealand license rights and distribution rights to Hong Kong and the rest of Asia Pacific, excluding China, Macau, Taiwan and Japan, to the Photosoft technology for all cancer indications. The Company’s wholly owned subsidiary is Epitech Dermal Science Pty Ltd.More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
IVX
CEO Podcast 		20/05/24 0 148
20/05/24 Last post  richiec Comments Created with Sketch.  0  Views Created with Sketch.  148 
IVX
Ann: Agreement with Major South Korean Pharma Group Hanlim 		13/05/24 4 1.6K
13/05/24 Last post  cashngrab Comments Created with Sketch.  4  Views Created with Sketch.  1.6K 
IVX
News: IVX Invion Ltd Announces Agreement With Major South Korean Pharma Group Hanlim 		08/05/24 0 130
TRENDING NEWS

Unlock the secrets of ASX healthcare investments - join industry leaders & innovators today!

Read More   right-arrow Created with Sketch.
NEWS
21 May 2024
08/05/24 Last post  Hot News Comments Created with Sketch.  0  Views Created with Sketch.  130 
IVX
InvInvion featured in leading industry publication Biotech Daily Australia's 		06/05/24 0 207
06/05/24 Last post  Rtj1953 Comments Created with Sketch.  0  Views Created with Sketch.  207 
IVX
Ann: Activities Report and Appendix 4C 		30/04/24 1 532
30/04/24 Last post  Rtj1953 Comments Created with Sketch.  1  Views Created with Sketch.  532 
IVX
Approval and Commencement of clinical Trials Australian Government Cancer. 		10/04/24 2 1.5K
10/04/24 Last post  cashflowmonday Comments Created with Sketch.  2  Views Created with Sketch.  1.5K 
IVX
Ann: INV043 With ICI Therapy Achieved 80% Tumour Control For ASCC 		29/03/24 18 7.3K
29/03/24 Last post  simonaw Comments Created with Sketch.  18  Views Created with Sketch.  7.3K 
IVX
Ann: Presentation at East-West Summit in Singapore 		05/03/24 0 400
05/03/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  400 

See All Discussions arrow Created with Sketch.

Timeline

Agreement with Major South Korean Pharma Group Hanlim
08 May 09:16
 
Activities Report and Appendix 4C
30 Apr 13:12
 
Presentation at East-West Summit in Singapore
05 Mar 08:37
 
INV043 With ICI Therapy Achieved 80% Tumour Control For ASCC
04 Mar 16:06
 
Appendix 4D and Half Year Financial Report
28 Feb 09:29
 
Agreement with Dr.inB to develop Photosoft treatment for HPV
23 Feb 09:04
 
View More arrow Created with Sketch.

Featured News

TMB Tambourah gets state govt grant for drilling at namesake gold project in WA
right-arrow Created with Sketch.
RDN Raiden ready to drill, with final heritage work ticked off at Andover North
right-arrow Created with Sketch.
HAR Haranga shores up confidence in Sanela as data points to potential
right-arrow Created with Sketch.
AUQ Alara sending first copper from Omani Al Wash-hi Majaza plant next week
right-arrow Created with Sketch.
ATC Altech taps investors for $3.7M as EU lithium plans evolve into shape
right-arrow Created with Sketch.
CY5 Pegmatites under glacial cover excite Cygnus in Quebec
right-arrow Created with Sketch.
(20min delay)
Last
0.6¢ 		Change
0.001(10.0%) 		Mkt cap ! $35.33M
Open High Low Value Volume
0.6¢ 0.6¢ 0.5¢ $1.129K 205.6K

Buyers (Bids)

No. Vol. Price($)
6 2359014 0.5¢
 

Sellers (Offers)

Price($) Vol. No.
0.6¢ 10183366 10
View Market Depth
Last trade - 13.22pm 21/05/2024 (20 minute delay) ?
IVX (ASX) Chart

Top Stories

The High Fiving ASX oil and gas stock star champions are...

The top five ASX oil and gas companies over the past five years were Pancontinental, Melbana, Strike Energy, Elixir and Karoon.
Pacific Edge revenues up, cash costs down on reorganisation Pacific Edge Ltd has balanced a drop in cash costs with falls in total cash at the end of the 2024 Financial Year.
Gas critical to Australia's renewable future, say political and industry leaders. Australian political and industry leaders agree that gas has an important role to play in the country's renewable future.
Market Close: ASX closes flattish as traders shrug off new NASDAQ record The ASX200 closed just 12 points down (0.15%) as the local markets shrugged off another record close for the NASDAQ on Monday night.
Havilah drills molybdenum up to 0.21% and gold at 4.79 g/t at SA's Kalkaroo Havilah Resources Ltd has made a significant discovery of molybdenum through drilling at its Kalkaroo deposit in the South Australia.

Featured News

NEWS The High Five ASX oil and gas stock star champions are...
right-arrow Created with Sketch.
TMB Tambourah gets state govt grant for drilling at namesake gold project in WA
right-arrow Created with Sketch.
AGE Alligator Energy notches up on uranium drilling start, but still early days
right-arrow Created with Sketch.
CY5 Pegmatites under glacial cover excite Cygnus in Quebec
right-arrow Created with Sketch.
RDN Raiden ready to drill, with final heritage work ticked off at Andover North
right-arrow Created with Sketch.
VUL Vulcan smashes through $5/sh resistance level as final funding stage live
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.